Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho

NCT01459120 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1800

Last updated 2012-02-09

No results posted yet for this study

Summary

The purpose of this trial is to determine if door-to-door is more effective than community gathering in providing voluntary HIV counseling and testing (VCT) in communities in rural Lesotho. The voluntary HIV counseling and testing will be proposed as an integrated part of a package of proposed services. The package consists of: Blood-pressure measurement, blood-glucose measurement, Body-mass-index (adults), weight for height (children), catch-up vaccinations, deworming (children) Vitamin A (children \& young women), family planning for eligible women, Tuberculosis screening and HIV counseling and testing.

Conditions

Interventions

OTHER

Door-to-door

Health workers propose the integrated service package including VCT at the peoples' homes (home-based testing).

OTHER

Pitso

Health care workers propose the integrated service package including VCT through community gatherings ("Pitso").

Sponsors & Collaborators

  • Paray Mission Hospital, Thaba-Tseka

    collaborator UNKNOWN
  • Seboche Hospital, Botha-Bothe

    collaborator UNKNOWN
  • SolidarMed

    lead OTHER

Principal Investigators

  • Motlomelo Masetsibi · SolidarMed

  • Niklaus Labhardt, MD, MIH · SolidarMed

  • Karolin Pfeiffer, MD, McommH · SolidarMed

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • Lesotho

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01459120 on ClinicalTrials.gov